Physician profile
Veronica Rivera
NPI 1932634664
$2,275.56
in general payments reported to CMS, 2019-2025
17 companies · $574 in 2025
The $574 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.10 · 2022: $208 · 2023: $352 · 2024: $1,095 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671 · Education: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.05 |
| Education | $350.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $684.22 | 2021-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $422.28 | 2023-2025 | Sotyktu |
| Abbvie INC. | $347.17 | 2021-2025 | |
| Incyte Corporation | $239.22 | 2023-2025 | Opzelura |
| Amgen INC. | $115.32 | 2022-2023 | Otezla |
| Novartis Pharmaceuticals Corporation | $107.33 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.52 | 2022-2023 | Spevigo |
| Pfizer INC. | $56.15 | 2022-2023 | |
| Arcutis Biotherapeutics, INC. | $36.14 | 2024 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $30.70 | 2022 | |
| Lilly USA, LLC | $27.38 | 2022 | |
| Genzyme Corporation | $25.43 | 2024 | |
| Verrica Pharmaceuticals INC. | $25.00 | 2024 | Ycanth |
| Organon LLC | $24.39 | 2025 | |
| Phadia US INC. | $19.86 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $18.78 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.